Compare Wockhardt with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs UNICHEM LAB - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT UNICHEM LAB WOCKHARDT/
UNICHEM LAB
 
P/E (TTM) x -53.8 -163.3 - View Chart
P/BV x 1.2 0.9 133.0% View Chart
Dividend Yield % 0.0 1.5 0.2%  

Financials

 WOCKHARDT   UNICHEM LAB
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
UNICHEM LAB
Mar-19
WOCKHARDT/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs1,012292 346.6%   
Low Rs532182 292.0%   
Sales per share (Unadj.) Rs355.9167.7 212.2%  
Earnings per share (Unadj.) Rs-60.3-3.6 1,660.2%  
Cash flow per share (Unadj.) Rs-46.85.9 -787.0%  
Dividends per share (Unadj.) Rs0.014.00 0.3%  
Dividend yield (eoy) %01.7 0.1%  
Book value per share (Unadj.) Rs257.8372.3 69.3%  
Shares outstanding (eoy) m110.6370.38 157.2%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.21.4 153.4%   
Avg P/E ratio x-12.8-65.3 19.6%  
P/CF ratio (eoy) x-16.539.9 -41.4%  
Price / Book Value ratio x3.00.6 470.2%  
Dividend payout %0-110.2 0.0%   
Avg Mkt Cap Rs m85,37916,680 511.9%   
No. of employees `0006.32.6 240.4%   
Total wages/salary Rs m9,3712,393 391.6%   
Avg. sales/employee Rs Th6,295.04,535.2 138.8%   
Avg. wages/employee Rs Th1,498.3919.8 162.9%   
Avg. net profit/employee Rs Th-1,066.3-98.2 1,085.8%   
INCOME DATA
Net Sales Rs m39,36911,801 333.6%  
Other income Rs m1,202984 122.2%   
Total revenues Rs m40,57112,785 317.3%   
Gross profit Rs m18-835 -2.2%  
Depreciation Rs m1,495674 222.0%   
Interest Rs m2,55575 3,397.5%   
Profit before tax Rs m-2,830-600 471.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m257-343 -74.8%   
Profit after tax Rs m-6,669-256 2,609.7%  
Gross profit margin %0-7.1 -0.7%  
Effective tax rate %-9.157.3 -15.9%   
Net profit margin %-16.9-2.2 782.2%  
BALANCE SHEET DATA
Current assets Rs m33,79620,384 165.8%   
Current liabilities Rs m26,9175,029 535.2%   
Net working cap to sales %17.5130.1 13.4%  
Current ratio x1.34.1 31.0%  
Inventory Days Days79105 75.7%  
Debtors Days Days89135 66.2%  
Net fixed assets Rs m39,6649,023 439.6%   
Share capital Rs m553141 392.9%   
"Free" reserves Rs m27,96826,058 107.3%   
Net worth Rs m28,52226,199 108.9%   
Long term debt Rs m21,7310-   
Total assets Rs m81,62031,496 259.1%  
Interest coverage x-0.1-7.0 1.5%   
Debt to equity ratio x0.80-  
Sales to assets ratio x0.50.4 128.7%   
Return on assets %-5.0-0.6 880.3%  
Return on equity %-23.4-1.0 2,397.2%  
Return on capital %-7.7-2.0 383.9%  
Exports to sales %069.4 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA8,188 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,8078,188 119.8%   
Fx outflow Rs m1,789596 300.1%   
Net fx Rs m8,0197,592 105.6%   
CASH FLOW
From Operations Rs m684-3,278 -20.9%  
From Investments Rs m6,302-2,860 -220.4%  
From Financial Activity Rs m-7,695-24 31,796.3%  
Net Cashflow Rs m-664-4,690 14.2%  

Share Holding

Indian Promoters % 74.5 50.1 148.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 15.1 15.2%  
FIIs % 7.7 3.0 256.7%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 31.7 48.6%  
Shareholders   67,757 20,176 335.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   TORRENT PHARMA  ALKEM LABORATORIES  AJANTA PHARMA  SANOFI INDIA  ALEMBIC PHARMA  

Compare WOCKHARDT With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat; Power and Telecom Stocks Witness Buying(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

WOCKHARDT Announces Quarterly Results (3QFY20); Net Profit Up 125.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, WOCKHARDT has posted a net profit of Rs 192 m (up 125.0% YoY). Sales on the other hand came in at Rs 9 bn (down 16.9% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio(Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

Large Opportunities Are Coming Our Way

Aug 5, 2020

Kenneth Andrade tells us why stocks will bounce back strongly and what he's bullish on.

How to Buy Gold and Silver(Fast Profits Daily)

Jul 27, 2020

In this video I'll show you how to buy bullion the right way.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Aug 7, 2020 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT 8-QTR ANALYSIS

COMPARE WOCKHARDT WITH

MARKET STATS